Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
1980550 citationsCarlo Patrono, Giovanni Ciabattoni et al.Thrombosis Researchprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of E Pinca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Pinca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Pinca more than expected).
This network shows the impact of papers produced by E Pinca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Pinca. The network helps show where E Pinca may publish in the future.
Co-authorship network of co-authors of E Pinca
This figure shows the co-authorship network connecting the top 25 collaborators of E Pinca.
A scholar is included among the top collaborators of E Pinca based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with E Pinca. E Pinca is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Wennmalm, A, et al.. (1983). Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide-stimulated cerebral blood flow in man.. PubMed. 12. 351–5.10 indexed citations
3.
Patrono, Carlo, Giovanni Ciabattoni, Paola Patrignani, et al.. (1983). Evidence for a renal origin of urinary thromboxane B2 in health and disease.. PubMed. 11. 493–8.54 indexed citations
Ciabattoni, Giovanni, et al.. (1980). Biologic and methodologic variables affecting urinary prostaglandin measurement.. PubMed. 6. 207–12.7 indexed citations
11.
Patrono, Carlo, et al.. (1980). Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function.. PubMed. 6. 187–91.37 indexed citations
12.
Patrono, Carlo, Giovanni Ciabattoni, E Pinca, et al.. (1980). Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thrombosis Research. 17(3-4). 317–327.550 indexed citations breakdown →
13.
Patrono, Carlo, Giovanni Ciabattoni, Francesco Pugliese, et al.. (1980). Radioimmunoassay measurement of stable metabolites of platelet arachidonic acid: a convenient method for the in vitro and ex vivo evaluation of cyclo-oxygenase inhibitors.. PubMed. 7. 256–9.4 indexed citations
14.
Patrono, Carlo, et al.. (1979). Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.. PubMed. 138–46.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.